Renal Cancer - Results from #2460

Comprehensive Analysis of the ATP-binding Cassette Subfamily B Across Renal Cancers Identifies ABCB8 Overexpression in Phenotypically Aggressive Clear Cell Renal Cell Carcinoma. October 7, 2020

Development of a DNA Methylation-Based Diagnostic Signature to Distinguish Benign Oncocytoma From Renal Cell Carcinoma. October 7, 2020

Final Overall Survival Results from a Phase 3 Study to Compare Tivozanib to Sorafenib as Third- or Fourth-line Therapy in Subjects with Metastatic Renal Cell Carcinoma. October 6, 2020

TiNivo: Safety and Efficacy of Tivozanib-Nivolumab Combination Therapy in Patients with Metastatic Renal Cell Carcinoma. October 6, 2020

The Role of Metabolic Factors in Renal Cancers. October 6, 2020

Integrating Phenotypic Search and Phosphoproteomic Profiling of Active Kinases for Optimization of Drug Mixtures for RCC Treatment. October 5, 2020

Consensus paper: current state of first- and second-line therapy in advanced clear-cell renal cell carcinoma. October 5, 2020

Tobacco smoking induces metabolic reprogramming of renal cell carcinoma. October 5, 2020

Nephrometry Scores: a validation of three systems for peri-operative outcomes in retroperitoneal robotic partial nephrectomy. October 2, 2020

Long non‑coding RNA PLK1S1 was associated with renal cell carcinoma progression by interacting with microRNA‑653 and altering C‑X‑C chemokine receptor 5 expression. October 2, 2020

Urinary Human Kidney Injury Molecule-1 (hKIM-1) Is Not Increased in Patients with Renal Cell Carcinoma. October 2, 2020

Resistance to Pembrolizumab and Axitinib in Renal Cell Carcinoma: Clinical and Genomic Evaluation. October 1, 2020

Identification of key genes and functions of circulating tumor cells in multiple cancers through bioinformatic analysis. October 1, 2020

The anti-inflammatory protein MCPIP1 inhibits the development of ccRCC by maintaining high levels of tumour suppressors. October 1, 2020

Development and Validation of a Clinical Prognostic Model Based on Immune-Related Genes Expressed in Clear Cell Renal Cell Carcinoma. September 30, 2020

Prognostic Role of Prothrombin Time Activity, Prothrombin Time, Albumin/Globulin Ratio, Platelets, Sex, and Fibrinogen in Predicting Recurrence-Free Survival Time of Renal Cancer. September 30, 2020

Comprehensive analysis on the expression levels and prognostic values of LOX family genes in kidney renal clear cell carcinoma. September 30, 2020

Comprehensive geriatric assessment is an independent prognostic factor in older patients with metastatic renal cell cancer treated with first-line Sunitinib or Pazopanib: a single center experience. September 29, 2020

CRISPR/Cas9 genome-wide loss-of-function screening identifies druggable cellular factors involved in sunitinib resistance in renal cell carcinoma. September 29, 2020

Identification of KIF18B as a Hub Candidate Gene in the Metastasis of Clear Cell Renal Cell Carcinoma by Weighted Gene Co-expression Network Analysis. September 29, 2020

Page 124 of 456